Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
Abstract Background Although intrinsic immune-evasion is important in cancer proliferation, metastasis and response to treatment, it is unclear whether intrinsic immune-evasion patterns of gliomas can aid in predicting clinical prognosis and determining treatment. Methods A total of 182 immune-evasi...
Main Authors: | Zewei Tu, Qiankun Ji, Qing Han, Xiaoyan Long, Jingying Li, Lei Wu, Kai Huang, Xingen Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-022-09984-5 |
Similar Items
-
A gene signature predicting prognosis of patients with lower-grade gliomas receiving temozolomide therapy
by: Yanzhi Wan, et al.
Published: (2023-11-01) -
Long-term adjuvant administration of temozolomide impacts serum ions concentration in high-grade glioma
by: Liyun Zhong, et al.
Published: (2022-02-01) -
Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up
by: Zhuang Kang, et al.
Published: (2023-06-01) -
Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis
by: Jun-Hai Tang, et al.
Published: (2019-12-01) -
Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gliomas
by: Junzhe Liu, et al.
Published: (2022-07-01)